Mice bearing CD38+ RPMI 8226 tumours were i.v. injected with either 111In-DPTA-2F8 alone, 111In-DPTA-2F8 in combination with 150 mg/kg gelofusin or 111In-DTPA-R3B23. The gene discussed is CD38; the disease is neoplasm.